WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.
<TABLE> <S> <C>
<ARTICLE> 6
<CIK> 0001029068
<NAME> ORBITEX GROUP OF FUNDS
<SERIES>
<NUMBER> 5
<NAME> HEALTH & BIOTECHNOLOGY FUND - C
<MULTIPLIER> 1000
<S> <C>
<PERIOD-TYPE> 4-MOS
<FISCAL-YEAR-END> APR-30-2000
<PERIOD-END> APR-30-2000
<INVESTMENTS-AT-COST> 211808
<INVESTMENTS-AT-VALUE> 181042
<RECEIVABLES> 11668
<ASSETS-OTHER> 77
<OTHER-ITEMS-ASSETS> 0
<TOTAL-ASSETS> 192787
<PAYABLE-FOR-SECURITIES> 11773
<SENIOR-LONG-TERM-DEBT> 0
<OTHER-ITEMS-LIABILITIES> 1279
<TOTAL-LIABILITIES> 13052
<SENIOR-EQUITY> 0
<PAID-IN-CAPITAL-COMMON> 232509
<SHARES-COMMON-STOCK> 2222
<SHARES-COMMON-PRIOR> 0
<ACCUMULATED-NII-CURRENT> 0
<OVERDISTRIBUTION-NII> 0
<ACCUMULATED-NET-GAINS> (22008)
<OVERDISTRIBUTION-GAINS> 0
<ACCUM-APPREC-OR-DEPREC> (30766)
<NET-ASSETS> 179735
<DIVIDEND-INCOME> 56
<INTEREST-INCOME> 228
<OTHER-INCOME> 0
<EXPENSES-NET> 1012
<NET-INVESTMENT-INCOME> (728)
<REALIZED-GAINS-CURRENT> (22008)
<APPREC-INCREASE-CURRENT> (30766)
<NET-CHANGE-FROM-OPS> (53502)
<EQUALIZATION> 0
<DISTRIBUTIONS-OF-INCOME> 0
<DISTRIBUTIONS-OF-GAINS> 0
<DISTRIBUTIONS-OTHER> 0
<NUMBER-OF-SHARES-SOLD> 2625
<NUMBER-OF-SHARES-REDEEMED> 403
<SHARES-REINVESTED> 0
<NET-CHANGE-IN-ASSETS> 179735
<ACCUMULATED-NII-PRIOR> 0
<ACCUMULATED-GAINS-PRIOR> 0
<OVERDISTRIB-NII-PRIOR> 0
<OVERDIST-NET-GAINS-PRIOR> 0
<GROSS-ADVISORY-FEES> 533
<INTEREST-EXPENSE> 0
<GROSS-EXPENSE> 1353
<AVERAGE-NET-ASSETS> 60288
<PER-SHARE-NAV-BEGIN> 16.33
<PER-SHARE-NII> (0.12)
<PER-SHARE-GAIN-APPREC> 1.07
<PER-SHARE-DIVIDEND> 0
<PER-SHARE-DISTRIBUTIONS> 0
<RETURNS-OF-CAPITAL> 0
<PER-SHARE-NAV-END> 17.28
<EXPENSE-RATIO> 2.60
[AVG-DEBT-OUTSTANDING] 0
[AVG-DEBT-PER-SHARE] 0
</TABLE>
